Business Context and Reporting Period
Company: The Cooper Companies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 30, 1995
Business Overview: The Company develops, manufactures, and markets healthcare products (contact lenses, surgical instruments) and provides healthcare services through psychiatric facilities. The reporting period covers the three and six months ended April 30, 1995.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended Apr 30, 1995 |
Six Months Ended Apr 30, 1994 |
|---|---|---|
| Net Operating Revenue | $47,004 | $47,362 |
| Net Income (Loss) | $880 | $(9,000) |
| Net Income Per Share | $0.03 | $(0.30) |
| Cash Flow from Operations | $(5,958) | $(4,372) |
| Cash and Equivalents (End of Period) | $4,502 | $9,092 |
| Total Debt (Current + Long-term) | $46,401 | $47,442 |
| Stockholders' Deficit | $(2,157) | $(3,654) |
Margins (Six Months Ended Apr 30, 1995):
- Product Gross Margin: 67% (up from 65% in 1994)
- Service Profit Margin: 5.0% (down from 10.5% in 1994)
Material Changes vs. Prior Period
- Profitability Turnaround: The Company reported a net income of $880,000 for the six months ended April 30, 1995, compared to a net loss of $9,000,000 in the same period in 1994. This improvement is largely due to a $468,000 credit for settlement of disputes and a significant reduction in legal and restructuring costs compared to the prior year.
- Revenue Stability: Total net operating revenue remained relatively flat, decreasing slightly by 0.8% ($358,000) year-over-year. Product sales increased 4%, while service revenue decreased 6% due to managed care pressures and disputes at Hampton Hospital.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased 21% ($3.66 million) due to the resolution of legal matters and corporate staffing reductions. Research and Development (R&D) expenses decreased 19% ($453,000) as the Company shifted focus away from long-term, high-risk projects.
- Liquidity: Cash and cash equivalents decreased by $5.8 million to $4.5 million, driven by net cash used in operating activities of $5.96 million, primarily for legal settlements and fees.
Guidance, Outlook, and Risks
Management Commentary & Strategy:
Management states that financial condition stabilized significantly in the second quarter of 1995. The Company has adjusted its corporate focus to favor acquiring products ready for market rather than funding long-term R&D. Management believes the Company is now positioned to generate sufficient cash for internal operating needs absent extraordinary events.
Risks and Contingencies:
- Legal Proceedings: The Company is involved in multiple legal actions, including shareholder derivative suits regarding alleged "trading schemes" and class actions regarding securities fraud. While settlements are in progress, there is no assurance they will be approved by the courts.
- Hampton Medical Group Dispute: A significant dispute with Hampton Medical Group (HMG) regarding fraudulent billing practices has reduced revenues and led to a settlement with Blue Cross. The Company intends to seek recovery from HMG but notes there can be no assurance of full recovery.
- Liquidity: The Company is exploring methods to raise additional capital and has a $8 million credit facility (with $1.4 million drawn) available for strategic acquisitions.
Investor Verification Checklist
- Legal Settlement Finality: Verify the status of court approvals for the shareholder derivative and class action settlements to confirm the $468,000 credit is secure.
- Hampton Hospital Recovery: Monitor the arbitration outcome with Hampton Medical Group and the ability to recover losses from the Blue Cross settlement.
- Cash Burn Rate: Assess the sustainability of the $5.96 million operating cash outflow and the timeline for achieving positive operating cash flow.
- Service Revenue Trends: Evaluate the impact of managed care trends on the psychiatric facility segment, which saw a 6% revenue decline and margin compression.
- Debt Obligations: Review the schedule for long-term debt repayments, including the 10% Senior Subordinated Secured Notes due 2003.